Selected research
Market Structure
Global Cinacalcet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cinacalcet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Cinacalcet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cinacalcet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cinacalcet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cinacalcet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cinacalcet include Teva, Sun Pharmaceutical, Shijiazhuang No. 4 Pharmaceutical Co., Ltd., Mylan, Amgen, Steris Healthcare PVT Ltd, Nexus Lifecare Private Limited, Cipla and Cinasun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Cinacalcet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cinacalcet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cinacalcet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cinacalcet market size, projected growth trends, production technologies, key applications, and end-use industries.
Cinacalcet Segment by Company
Teva
Sun Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Mylan
Amgen
Steris Healthcare PVT Ltd
Nexus Lifecare Private Limited
Cipla
Cinasun
Camber
Bts Synergy Pvt Ltd
Aurobindo Pharma
Cinacalcet Segment by Type
30 mg Tablets
60 mg Tablets
90 mg Tablets
Cinacalcet Segment by Application
Hospital
Drug store
Cinacalcet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinacalcet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cinacalcet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinacalcet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cinacalcet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cinacalcet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cinacalcet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cinacalcet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 30 mg Tablets
- 60 mg Tablets
- 90 mg Tablets
Applications
- Hospital
- Drug store
Companies covered
- Teva
- Sun Pharmaceutical
- Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
- Mylan
- Amgen
- Steris Healthcare PVT Ltd
- Nexus Lifecare Private Limited
- Cipla
- Cinasun
- Camber
- Bts Synergy Pvt Ltd
- Aurobindo Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cinacalcet Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cinacalcet Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cinacalcet Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cinacalcet Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cinacalcet Market Dynamics
- 2.1 Cinacalcet Industry Trends
- 2.2 Cinacalcet Industry Drivers
- 2.3 Cinacalcet Industry Opportunities and Challenges
- 2.4 Cinacalcet Industry Restraints
3 Cinacalcet Market by Manufacturers
- 3.1 Global Cinacalcet Revenue by Manufacturers (2021-2026)
- 3.2 Global Cinacalcet Sales by Manufacturers (2021-2026)
- 3.3 Global Cinacalcet Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cinacalcet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cinacalcet Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cinacalcet Manufacturers, Product Type & Application
- 3.7 Global Cinacalcet Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cinacalcet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cinacalcet Players Market Share by Revenue in 2025
- 3.8.3 2025 Cinacalcet Tier 1, Tier 2, and Tier 3
4 Cinacalcet Market by Type
- 4.1 Cinacalcet Type Introduction
- 4.1.1 30 mg Tablets
- 4.1.2 60 mg Tablets
- 4.1.3 90 mg Tablets
- 4.2 Global Cinacalcet Sales by Type
- 4.2.1 Global Cinacalcet Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cinacalcet Sales by Type (2021-2032)
- 4.2.3 Global Cinacalcet Sales Market Share by Type (2021-2032)
- 4.3 Global Cinacalcet Revenue by Type
- 4.3.1 Global Cinacalcet Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cinacalcet Revenue by Type (2021-2032)
- 4.3.3 Global Cinacalcet Revenue Market Share by Type (2021-2032)
5 Cinacalcet Market by Application
- 5.1 Cinacalcet Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drug store
- 5.2 Global Cinacalcet Sales by Application
- 5.2.1 Global Cinacalcet Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cinacalcet Sales by Application (2021-2032)
- 5.2.3 Global Cinacalcet Sales Market Share by Application (2021-2032)
- 5.3 Global Cinacalcet Revenue by Application
- 5.3.1 Global Cinacalcet Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cinacalcet Revenue by Application (2021-2032)
- 5.3.3 Global Cinacalcet Revenue Market Share by Application (2021-2032)
6 Global Cinacalcet Sales by Region
- 6.1 Global Cinacalcet Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cinacalcet Sales by Region (2021-2032)
- 6.2.1 Global Cinacalcet Sales by Region (2021-2026)
- 6.2.2 Global Cinacalcet Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cinacalcet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cinacalcet Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cinacalcet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cinacalcet Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cinacalcet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cinacalcet Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cinacalcet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cinacalcet Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cinacalcet Revenue by Region
- 7.1 Global Cinacalcet Revenue by Region
- 7.1.1 Global Cinacalcet Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cinacalcet Revenue by Region (2021-2026)
- 7.1.3 Global Cinacalcet Revenue by Region (2027-2032)
- 7.1.4 Global Cinacalcet Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cinacalcet Revenue (2021-2032)
- 7.2.2 North America Cinacalcet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cinacalcet Revenue (2021-2032)
- 7.3.2 Europe Cinacalcet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cinacalcet Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cinacalcet Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cinacalcet Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cinacalcet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Cinacalcet Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Sun Pharmaceutical
- 8.2.1 Sun Pharmaceutical Company Information
- 8.2.2 Sun Pharmaceutical Business Overview
- 8.2.3 Sun Pharmaceutical Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sun Pharmaceutical Cinacalcet Product Portfolio
- 8.2.5 Sun Pharmaceutical Recent Developments
- 8.3 Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
- 8.3.1 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Company Information
- 8.3.2 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Cinacalcet Product Portfolio
- 8.3.5 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Recent Developments
- 8.4 Mylan
- 8.4.1 Mylan Company Information
- 8.4.2 Mylan Business Overview
- 8.4.3 Mylan Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mylan Cinacalcet Product Portfolio
- 8.4.5 Mylan Recent Developments
- 8.5 Amgen
- 8.5.1 Amgen Company Information
- 8.5.2 Amgen Business Overview
- 8.5.3 Amgen Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Amgen Cinacalcet Product Portfolio
- 8.5.5 Amgen Recent Developments
- 8.6 Steris Healthcare PVT Ltd
- 8.6.1 Steris Healthcare PVT Ltd Company Information
- 8.6.2 Steris Healthcare PVT Ltd Business Overview
- 8.6.3 Steris Healthcare PVT Ltd Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Steris Healthcare PVT Ltd Cinacalcet Product Portfolio
- 8.6.5 Steris Healthcare PVT Ltd Recent Developments
- 8.7 Nexus Lifecare Private Limited
- 8.7.1 Nexus Lifecare Private Limited Company Information
- 8.7.2 Nexus Lifecare Private Limited Business Overview
- 8.7.3 Nexus Lifecare Private Limited Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Nexus Lifecare Private Limited Cinacalcet Product Portfolio
- 8.7.5 Nexus Lifecare Private Limited Recent Developments
- 8.8 Cipla
- 8.8.1 Cipla Company Information
- 8.8.2 Cipla Business Overview
- 8.8.3 Cipla Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Cipla Cinacalcet Product Portfolio
- 8.8.5 Cipla Recent Developments
- 8.9 Cinasun
- 8.9.1 Cinasun Company Information
- 8.9.2 Cinasun Business Overview
- 8.9.3 Cinasun Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Cinasun Cinacalcet Product Portfolio
- 8.9.5 Cinasun Recent Developments
- 8.10 Camber
- 8.10.1 Camber Company Information
- 8.10.2 Camber Business Overview
- 8.10.3 Camber Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Camber Cinacalcet Product Portfolio
- 8.10.5 Camber Recent Developments
- 8.11 Bts Synergy Pvt Ltd
- 8.11.1 Bts Synergy Pvt Ltd Company Information
- 8.11.2 Bts Synergy Pvt Ltd Business Overview
- 8.11.3 Bts Synergy Pvt Ltd Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Bts Synergy Pvt Ltd Cinacalcet Product Portfolio
- 8.11.5 Bts Synergy Pvt Ltd Recent Developments
- 8.12 Aurobindo Pharma
- 8.12.1 Aurobindo Pharma Company Information
- 8.12.2 Aurobindo Pharma Business Overview
- 8.12.3 Aurobindo Pharma Cinacalcet Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Aurobindo Pharma Cinacalcet Product Portfolio
- 8.12.5 Aurobindo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cinacalcet Value Chain Analysis
- 9.1.1 Cinacalcet Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cinacalcet Production Mode & Process
- 9.2 Cinacalcet Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cinacalcet Distributors
- 9.2.3 Cinacalcet Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst